RXL Stock Overview
ProShares Trust - ProShares Ultra Health Care is an exchange traded fund launched and managed by ProShare Advisors LLC.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
ProShares Trust - ProShares Ultra Health Care Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$103.06 |
52 Week High | US$106.53 |
52 Week Low | US$74.44 |
Beta | 0 |
1 Month Change | 0.67% |
3 Month Change | 14.82% |
1 Year Change | 27.37% |
3 Year Change | 33.74% |
5 Year Change | 101.70% |
Change since IPO | 1,059.93% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
RXL | US Capital Markets | US Market | |
---|---|---|---|
7D | 0.09% | 0.6% | 1.0% |
1Y | 27.4% | 31.9% | 31.2% |
Return vs Industry: RXL underperformed the US Capital Markets industry which returned 31.9% over the past year.
Return vs Market: RXL underperformed the US Market which returned 31.2% over the past year.
Price Volatility
RXL volatility | |
---|---|
RXL Average Weekly Movement | 2.4% |
Capital Markets Industry Average Movement | 3.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RXL has not had significant price volatility in the past 3 months.
Volatility Over Time: RXL's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | n/a | n/a | https://www.proshares.com/our-etfs/leveraged-and-inverse/rxl |
ProShares Trust - ProShares Ultra Health Care is an exchange traded fund launched and managed by ProShare Advisors LLC. The fund invests in public equity markets of the United States. The fund invests through derivatives in stocks of companies operating across health care sectors.
ProShares Trust - ProShares Ultra Health Care Fundamentals Summary
RXL fundamental statistics | |
---|---|
Market cap | US$93.54m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs RXL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RXL income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did RXL perform over the long term?
See historical performance and comparison